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phy were the main diagnostic tool, however, other diag-
nostic modalities (C-MRI and C-CT) were helpful in
offering further diagnostic information and surgical plan-
ning. Of the 16 patients, 8 patients were operated on as
an urgent or emergency. Among the 16 patients, 9
(56.25%) patients were operated for Myxoma excision.
right ventricular sarcoma (1), metastactic leiomyosar-
coma (2), metastatic sacral sarcoma (1), and metastatic
renal cell carcinoma (2), and Bachets disease (1). There
were no in-hospital mortality and all patient had symp-
tomatic improvements.
Conclusion: Cardiac tumours still represent a chal-
lenging condition. Our review shows that metastatic
tumours represent almost 50% of all our cardiac tumours.
Appropriate available diagnostic modalities is crucial, as
currently prompt complete surgical removal is the only
therapeutic & palliative option and offers best chances
of survival.
http://dx.doi:10.1016/j.jsha.2013.03.038
Oral anticoagulation throughout pregnancy in
patients with mechanical heart valve prosthesis:
Safe alternatives
Ahmed Hassouna, Ahmed Teima, Ayman Ammar,
Yasser Elnahas, Mohamed Badawi
Objectives: Small dose of Warfarin (65 mg/day) was
suggested as being safe in pregnant patients with
mechanical heart valve prosthesis (MHVP) however; no
other oral anticoagulant (OA) alternative has been pro-
posed to cases failing to achieve their target INR. We
aimed to suggest the alternative use/shift of those cases
to our previously reported safe (OA) Phenindione
(6100 mg/day) and to compare both regimens.
Methods: Eighty-seven females with 106 bileaflet
MHVP implanted in the aortic (10; 11.5%), mitral (58;
66.7%) or both positions (19; 21.8%) continued OA
throughout pregnancy, with restriction of daily doses to
5 mg Warfarin or 100 mg Phenindione. Patients were
allowed to cross over if failed to achieve their target
INR: 2-3.5. Aspirin (100 mg/day) was supplemented,
starting second trimester.
Results: Out of 59 patients initially receiving Warfa-
rin, 15 (25.4%) shifted to Phenindione, compared to none
of 28 patients originally receiving Phenindione
(P = 0.002). Mean INR and daily OA dose for 44 patients
remaining on Warfarin and 43 patients receiving Phenin-
dione were: 2.39 ± 0.34 versus 2.25 ± 0.2 (P > 0.05) and
3.9 ± 1.07 mg versus 79.3 ± 18.5 mg; respectively. Mater-
nal complications were six cases of resolved vaginal
bleeding (6.9%). There were no cases of embryopathy
or prematurity. Fetal outcomes included 68 live births
(78.2%), seven abortions (8%), two fetal loss (2.3%); all
insignificantly related to OA dose or INR level.
Conclusion: Although 65 mg Warfarin per day can
be safe during pregnancy, yet it cannot always achieve
the target INR and 6100 mg of Phenindione can be con-
sidered as a comparatively safe alternative.
http://dx.doi:10.1016/j.jsha.2013.03.039
The aortic translocation (Nikaidoh) procedure: Ini-
tial experience
A. Elwy, A. Al Saeedi, H. Alqethamy, Y. AlFariedi,
A. Raghib, K. Alnajashi, A. Khoja, R. Di Donato
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Objective: Midterm follow-up is analyzed after the
aortic translocation (Nikaidoh) procedure, an alternative
to the Rastelli procedure for ventriculoarterial discor-
dance, ventricular septal defect, and pulmonary stenosis
especially in cases with small or inlet VSD.
Methods: Seven patients underwent a Nikaidoh pro-
cedure at a median age of 3.3 years (0.9–9.3 years). The
native aortic valve was translocated from the right to
the left ventricular outflow tract by mobilization of the
aortic root.Four patients with coronary transfer as
the right coronary artery reimplanted as a button while
the other three patients had no coronary transfer. The
conal septum was divided in all patients. The right
ventricular outflow tract was reconstructed with valved
conduit. The median follow-up was 18 months (0.3–4
years). Left ventricular outflow tract obstruction and
aortic insufficiency were assessed by echocardiography.
Results: There were no deaths. Right ventricular to
Pulmonary artery conduit change were required in 2
patients (28.6%). No patient had any left ventricular out-
flow tract obstruction or aortic insufficiency more than
mild. All patients are doing well at last follow up.
Conclusion: The Nikaidoh is a valid alternative to
Rastelli or REV operations. It appears particularly indi-
cated in patients with TGA,VSD and LV outflow obstruc-
tion with small or inlet VSD.
http://dx.doi:10.1016/j.jsha.2013.03.040
Short-term outcome of coronary artery bypass graft
surgery in end stage renal failure dialysis-depen-
dent patients
Ahmed Ibrahim Rezk
Background: Patients with end-stage renal disease
(ESRD) requiring dialysis who undergo coronary artery
bypass graft surgery (CABG) are at significant risk for
perioperative morbidity and mortality. We describe our
own experience in such high risk subgroup of patients.
Methods: Over four years period, a retrospective
analysis of fifteen patients with dialysis-dependent renal
failure who underwent coronary artery bypass grafting.
Mean age was 55 ± 12 years. Except from one patient
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